Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
U.S. signs agreement with AstraZeneca to develop, supply COVID-19 antibody treatment [View all]
Source: Reuters
HEALTHCARE & PHARMACEUTICALS
OCTOBER 9, 2020 4:51 PM UPDATED 2 HOURS AGO
U.S. signs agreement with AstraZeneca to develop, supply COVID-19 antibody treatment
(Reuters) - The U.S. government on Friday signed an agreement with AstraZeneca Plc AZN.L worth $486 million to develop and secure supplies of up to 100,000 doses of COVID-19 antibody treatment, a similar class of drugs that was used to treat President Donald Trump.
The U.S. health agency will provide the funding to AstraZeneca for two Phase 3 clinical trials under operation Warp Speed, which is aimed at speeding up treatments and vaccines for COVID-19.
One trial will evaluate the safety and efficacy of the experimental treatment to prevent infection for up to 12 months, in about 5,000 participants, while the second trial will evaluate post-exposure preventative and pre-emptive treatment in roughly 1,100 participants.
AstraZeneca said it plans to supply up to 100,000 doses starting towards the end of 2020 and the US Government can acquire up to an additional one million doses in 2021 under a separate agreement.
-snip-
OCTOBER 9, 2020 4:51 PM UPDATED 2 HOURS AGO
U.S. signs agreement with AstraZeneca to develop, supply COVID-19 antibody treatment
(Reuters) - The U.S. government on Friday signed an agreement with AstraZeneca Plc AZN.L worth $486 million to develop and secure supplies of up to 100,000 doses of COVID-19 antibody treatment, a similar class of drugs that was used to treat President Donald Trump.
The U.S. health agency will provide the funding to AstraZeneca for two Phase 3 clinical trials under operation Warp Speed, which is aimed at speeding up treatments and vaccines for COVID-19.
One trial will evaluate the safety and efficacy of the experimental treatment to prevent infection for up to 12 months, in about 5,000 participants, while the second trial will evaluate post-exposure preventative and pre-emptive treatment in roughly 1,100 participants.
AstraZeneca said it plans to supply up to 100,000 doses starting towards the end of 2020 and the US Government can acquire up to an additional one million doses in 2021 under a separate agreement.
-snip-
Read more: https://www.reuters.com/article/us-health-coronavirus-usa-astrazeneca/u-s-signs-agreement-with-astrazeneca-to-develop-supply-covid-19-antibody-treatment-idUSKBN26U2HQ
2 replies
= new reply since forum marked as read
= new reply since forum marked as read